Symmetry Medical is mailing the definitive proxy statement and prospectus regarding the agreement to sell its OEM solutions business and transfer shareholder ownership to the new company, Symmetry Surgical.
There will be a shareholder meeting on Dec. 4 to approve the transaction. The company hopes to complete the transaction swiftly after approval, but is still subject to customary closing conditions. There is no assurance on the ultimate timing of the proposed transaction and Symmetry Medical does not intend to provide regular updates on the progress.
However, there will be an announcement when the transaction is complete.
More articles on orthopedic devices:
Stryker hip implant settlement to exceed $1.4B—10 key facts
Orthopedic device market stock report—5 company updates
Alphatec Spine 3Q revenue up 2%: 10 key concepts